Waqar, S. N., Redman, M. W., Li, T., Minichiello, K., Dragnev, K. H., Borghaei, H., Bradley, J. D., Brahmer, J. R., Stinchcombe, T., Gray, J. E., Herbst, R. S., Reckamp, K. L., Gandara, D. R. (2026). Lung-MAP S1800E: A randomized phase II/III study of docetaxel and ramucirumab with or without cemiplimab for patients previously treated with platinum-based chemotherapy and immunotherapy for stage IV or recurrent non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8669